A new study highlights medical associations' financial ties with pharmaceutical and device companies; CDC data finds nearly 300 health care personnel have died of coronavirus disease 2019 (COVID-19); the federal government is permitting methadone deliveries for those with opioid use disorder or addiction.
In a cross-sectional study published in The BMJ, researchers investigated the extent of financial relationships between leaders of influential professional medical associations and different pharmaceutical and medical device companies. Of the 328 leaders in the study, 72% had financial ties to industry, while total payments for leaders between 2017 and 2019 amounted to almost $130 million. Ten professional medical associations were included in the study, including the American College of Cardiology and the American Society of Clinical Oncology. Researchers determined the median amount each leader received was $31,805 (interquartile range $1157 to $254,272). Investigators point out the payments raise questions about associations’ independence and integrity.New CDC data revealed that since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, nearly 300 health care personnel have died from the disease and close to 63,000 have been infected. However, of the data collected from 1,358,065 individuals information on health care personnel, status was only available for 21% of the total. In addition, of the nearly 63,000 cases, death status was only available for 57% of individuals infected. In comparison, on April 15, CDC reported only 27 deaths among health care personnel and more than 9000 cases in health care workers, according to NPR.The federal government is now permitting patients in quarantine to have methadone delivered. The medication for opioid addiction has to be taken every day and is normally picked up from a treatment center, NPR reports. According to data from April 2020, 3 million Americans currently live with opioid use disorder. Last month, New York City instituted a methadone delivery program so patients wouldn’t need to break quarantine to receive their next dose. However, only 70 deliveries have been made under the program, despite its capacity to carry out 1300 deliveries each month.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More